Form 4: Vertex Pharmaceuticals SVP Kristen Ambrose Reports Stock Disposal
SEC Form 4 Filing
Kristen Ambrose, SVP & Chief Accounting Officer of Vertex Pharmaceuticals, disposed of 1,241 shares of common stock on February 26, 2025, to cover tax obligations.
Summary
- On February 26, 2025, Kristen Ambrose, the SVP & Chief Accounting Officer of Vertex Pharmaceuticals, disposed of 1,241 shares of common stock.
- The transaction was executed at a price of $479.61 per share.
- Following the transaction, Ms. Ambrose directly owns 7,845 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to ensure transparency of insider transactions. This filing indicates a transaction by a senior officer of Vertex Pharmaceuticals.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Date of stock disposal transaction |
| 02/28/2025 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.